Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome

Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and hypertensive emergencies in pregnancy. Hydralazine-induced lupus was first described in 1953. Clinical presentation ranges from arthralgia, myalgia, petechiae, or rash to si...

Descripción completa

Detalles Bibliográficos
Autores principales: Aeddula, Narothama Reddy, Pathireddy, Samata, Ansari, Asif, Juran, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Rare Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6229221/
https://www.ncbi.nlm.nih.gov/pubmed/30413463
http://dx.doi.org/10.1136/bcr-2018-227161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6229221/
https://www.ncbi.nlm.nih.gov/pubmed/30413463
http://dx.doi.org/10.1136/bcr-2018-227161

Ejemplares similares